Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

This publication has 37 references indexed in Scilit:

• Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
  JNCI Journal of the National Cancer Institute, 1994
• C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
  Journal of Clinical Investigation, 1994
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
• The type 1 (EGFR-related) family of growth factor receptors and their ligands
  Progress in Growth Factor Research, 1992
• Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancer
  Molecular Carcinogenesis, 1992
• Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
  European Journal of Cancer and Clinical Oncology, 1991
• Expression of epidermal growth factor receptors in four histologic cell types of lung cancer
  Journal of Surgical Oncology, 1989
• Epidermal growth factor receptors in lung tumours
  The Journal of Pathology, 1987
• Human squamous cell lung cancers express increased epidermal growth factor receptors.
  Journal of Clinical Investigation, 1984